» Articles » PMID: 10349868

Effects of Erythropoietin on Neuronal Activity

Overview
Journal J Neurochem
Specialties Chemistry
Neurology
Date 1999 Jun 1
PMID 10349868
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Recently, erythropoietin (EPO) receptors and synthesis of EPO have been identified in the brain. To clarify the effects of EPO on neuronal cells, we investigated the effects of EPO on Ca2+ uptake, intracellular Ca2+ concentration, membrane potential, cell survival, release and biosynthesis of dopamine, and nitric oxide (NO) production in differentiated PC12 cells, which possess EPO receptors. EPO (10(-12)-10(-10) M) increased 45Ca2+ uptake and intracellular Ca2+ concentration in PC12 cells in a dose-related manner; these increases were inhibited by nicardipine (1 microM) or anti-EPO antibody (1:100 dilution). EPO induced membrane depolarization in PC12 cells. After a 5-day culture without serum and nerve growth factor (NGF), viable cell number decreased to 50% of that of the control cells cultured with serum and NGF. EPO (10(-13)-10(-10) M) increased the number of viable cells cultured without serum and NGF; this increase was blunted by nicardipine or anti-EPO antibody. Incubation with EPO (10(-13)-10(-10) M) stimulated mitogen-activated protein kinase activity in PC12 cells. EPO (10(-13)-10(-10) M) increased dopamine release from PC12 cells and tyrosine hydroxylase activity; these increases were sensitive to nicardipine or anti-EPO antibody. Following a 4-h incubation with EPO (10(-14)-10(-10) M), NO production was increased, which was blunted by nicardipine and anti-EPO antibody. In contrast, maximal NO synthase activity was not changed by EPO. These results suggest that EPO stimulates neuronal function and viability via activation of Ca2+ channels.

Citing Articles

Erythropoietin Produces a Dual Effect on Carotid Body Chemoreception in Male Rats.

Arias-Reyes C, Laouafa S, Zubieta-DeUrioste N, Joseph V, Bairam A, Schneider Gasser E Front Pharmacol. 2021; 12:727326.

PMID: 34594222 PMC: 8476757. DOI: 10.3389/fphar.2021.727326.


Unravelling the potential neuroprotective facets of erythropoietin for the treatment of Alzheimer's disease.

Kaur D, Behl T, Sehgal A, Singh S, Sharma N, Badavath V Metab Brain Dis. 2021; 37(1):1-16.

PMID: 34436747 DOI: 10.1007/s11011-021-00820-6.


Insights into Potential Targets for Therapeutic Intervention in Epilepsy.

Zavala-Tecuapetla C, Cuellar-Herrera M, Luna-Munguia H Int J Mol Sci. 2020; 21(22).

PMID: 33202963 PMC: 7697405. DOI: 10.3390/ijms21228573.


Ventilatory and Autonomic Regulation in Sleep Apnea Syndrome: A Potential Protective Role for Erythropoietin?.

Andrade D, Haine L, Toledo C, Diaz H, Quintanilla R, Marcus N Front Physiol. 2018; 9:1440.

PMID: 30374309 PMC: 6196773. DOI: 10.3389/fphys.2018.01440.


Erythropoietin Induces Homeostatic Plasticity at Hippocampal Synapses.

Dias R, Rodrigues T, Rombo D, Ribeiro F, Rodrigues J, McGarvey J Cereb Cortex. 2017; 28(8):2795-2809.

PMID: 29053799 PMC: 6117472. DOI: 10.1093/cercor/bhx159.